The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VanCott, J. L.
Right arrow Articles by Saif, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VanCott, J. L.
Right arrow Articles by Saif, L. J.

The Journal of Immunology, Vol 150, Issue 9 3990-4000, Copyright © 1993 by American Association of Immunologists


ARTICLES

Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs

JL VanCott, TA Brim, RA Simkins and LJ Saif
Food Animal Health Research Program, Ohio Agricultural Research and Development Center, Ohio State University, Wooster 44691.

Antibody-secreting cells (ASC) were enumerated in gut- and bronchus- associated lymphoid tissues of pigs exposed to three antigenically related coronaviruses: virulent transmissible gastroenteritis virus (TGEV), attenuated TGEV, and porcine respiratory coronavirus (PRCV). Exposure of 11-day-old pigs to virulent TGEV resulted in severe gastroenteritis and virus shedding mainly in feces but also to a limited extent in nasal secretions. PRCV and attenuated TGEV exposure produced no clinical signs and only one pig given a high dose of attenuated TGEV shed virus in feces, but virus was shed from the nasal passages. Nasal virus titers were highest after PRCV inoculation of pigs. Mononuclear cells were isolated from spleens, mesenteric, and bronchial lymph nodes of pigs and assayed for virus-specific IgG and IgA antibody secretion by an enzyme-linked immunospot assay. Virus- specific ASC peaked at postinoculation days 12 to 24 and IgG-ASC outnumbered IgA-ASC in all tissues tested. The greatest numbers of ASC were in mesenteric lymph nodes of virulent TGEV-exposed pigs and in BLN of PRCV-exposed pigs. Attenuated TGEV induced intermediate ASC responses in the gut and respiratory tract. Secondary in vitro ASC responses to inactivated TGEV or PRCV paralleled the primary responses except in BLN where the numbers of memory ASC were high for both TGEV- and PRCV-exposed pigs. We conclude that: 1) a single exposure of pigs to PRCV either oral-nasally or by aerosol leads to potent systemic and bronchus-associated, but not gut-associated, ASC responses; 2) a high dose of attenuated TGEV (4 x 10(8) plaque-forming units) is more effective than PRCV (6 x 10(5) or 2 x 10(8) plaque-forming units) or a lower dose of attenuated TGEV (7 x 10(6) plaque-forming units) in eliciting gut-associated ASC; 3) although virulent and a high dose of attenuated TGEV induce high numbers of ASC in the tissues tested, virulent TGEV induces the most ASC in the gut and IgA-ASC in all lymphoid tissues; and 4) virus replication in the gut or respiratory tract is a major factor affecting the magnitude of an ASC response at that site and may be necessary for the recruitment of IgG- and IgA-ASC and memory cells in large numbers from other mucosal inductive sites. This unique model of mucosal immunity using antigenically related viruses with distinct tissue tropisms may help to clarify interactions of the various components of the common mucosal immune system.


This article has been cited by other articles:


Home page
J. Virol.Home page
X. Zhang, K. Alekseev, K. Jung, A. Vlasova, N. Hadya, and L. J. Saif
Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory Syndrome
J. Virol., May 1, 2008; 82(9): 4420 - 4428.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Souza, M. S. P. Azevedo, K. Jung, S. Cheetham, and L. J. Saif
Pathogenesis and Immune Responses in Gnotobiotic Calves after Infection with the Genogroup II.4-HS66 Strain of Human Norovirus
J. Virol., February 15, 2008; 82(4): 1777 - 1786.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Jung, K. P. Alekseev, X. Zhang, D.-S. Cheon, A. N. Vlasova, and L. J. Saif
Altered Pathogenesis of Porcine Respiratory Coronavirus in Pigs due to Immunosuppressive Effects of Dexamethasone: Implications for Corticosteroid Use in Treatment of Severe Acute Respiratory Syndrome Coronavirus
J. Virol., December 15, 2007; 81(24): 13681 - 13693.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Souza, S. M. Cheetham, M. S. P. Azevedo, V. Costantini, and L. J. Saif
Cytokine and Antibody Responses in Gnotobiotic Pigs after Infection with Human Norovirus Genogroup II.4 (HS66 Strain)
J. Virol., September 1, 2007; 81(17): 9183 - 9192.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. S. P. Azevedo, L. Yuan, S. Pouly, A. M. Gonzales, K. I. Jeong, T. V. Nguyen, and L. J. Saif
Cytokine Responses in Gnotobiotic Pigs after Infection with Virulent or Attenuated Human Rotavirus
J. Virol., January 1, 2006; 80(1): 372 - 382.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
B. Guy
Evaluation of Events Occurring at Mucosal Surfaces: Techniques Used To Collect and Analyze Mucosal Secretions and Cells
Clin. Vaccine Immunol., July 1, 2002; 9(4): 753 - 762.
[Full Text] [PDF]


Home page
J. Virol.Home page
I. Sola, J. Castilla, B. Pintado, J. M. Sanchez-Morgado, C. B. A. Whitelaw, A. J. Clark, and L. Enjuanes
Transgenic Mice Secreting Coronavirus Neutralizing Antibodies into the Milk
J. Virol., May 1, 1998; 72(5): 3762 - 3772.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Yuan, S.-Y. Kang, L. A. Ward, T. L. To, and L. J. Saif
Antibody-Secreting Cell Responses and Protective Immunity Assessed in Gnotobiotic Pigs Inoculated Orally or Intramuscularly with Inactivated Human Rotavirus
J. Virol., January 1, 1998; 72(1): 330 - 338.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.